Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

12. Dezember 2018 08:30 ET | Quelle: Cabaletta Bio

Cell Therapy Industry Pioneer, Gwendolyn Binder, Ph.D., to Join Cabaletta Bio Leadership Team

Dr. Binder is an expert in T cell product development, translational research and GMP manufacturing Joins Cabaletta Bio as Executive Vice President, Science & Technology on February 1, 2019 ...
15. November 2018 09:00 ET | Quelle: Cabaletta Bio

Cabaletta Bio Expands Scientific Regulatory, and Cell Therapy Manufacturing Expertise with Scientific Advisory Board Additions

-- Carl June, M.D., who led discovery and development of the breakthrough CAR T platform at the University of Pennsylvania -- Jay Siegel, M.D., former head of Office of Therapeutics Research and...
08. November 2018 09:00 ET | Quelle: Cabaletta Bio

Cabaletta Bio Emerges Out of University of Pennsylvania to Develop CAAR T Cell Technology to Treat B Cell-mediated Autoimmune Diseases

-- Signs exclusive license agreement and multi-year sponsored research agreements with University of Pennsylvania -- Completes $38 million Series A financing to advance lead asset, DSG3-CAART for...